Litcius/Paper detail

The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases

Jasvinder A. Singh

2023BioDrugs13 citationsDOI

Topics & Concepts

MedicineTofacitinibRheumatoid arthritisJanus kinaseAdverse effectSafety profileIntensive care medicinePharmacologyInternal medicineReceptorRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchPeripheral Neuropathies and Disorders
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases | Litcius